Prime Medicine (PRME) Treasury Shares (2021 - 2025)

Prime Medicine (PRME) has 5 years of Treasury Shares data on file, last reported at $3.5 million in Q4 2025.

• For the quarter ending Q4 2025, Treasury Shares changed 0.0% year-over-year to $3.5 million; the trailing twelve-month figure through Dec 2025 stood at $3.5 million (changed 0.0% YoY), and the FY2025 full-year result was $3.5 million, changed 0.0% from the prior year.
• Treasury Shares for Q4 2025 stood at $3.5 million, roughly flat from $3.5 million in the prior quarter.
• Across five years, Treasury Shares topped out at $10.8 million in Q4 2021 and bottomed at $3116.0 in Q2 2022.
• The 5-year median for Treasury Shares is $3.5 million (2024), against an average of $3.1 million.
• Peak annual rise in Treasury Shares reached 122902.86% in 2023, while the deepest fall reached 76.43% in 2023.
• A 5-year view of Treasury Shares shows it stood at $10.8 million in 2021, then plunged by 64.52% to $3.8 million in 2022, then sank by 76.43% to $903227.0 in 2023, then jumped by 284.46% to $3.5 million in 2024, then changed by 0.0% to $3.5 million in 2025.
• The last three Treasury Shares figures came in at $3.5 million (Q4 2025), $3.5 million (Q3 2025), and $3.5 million (Q2 2025), per Business Quant data.

Peer Comparison